Matches in Nanopublications for { ?s ?p "[TP53 mutations and cyclin-dependent kinase inhibitor 2A promoter methylation, but not alterations in the H-Ras and K-Ras genes, might be involved in the malignant progression of pleomorphic adenomas into carcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP132284.RA6jbEI-skD8kY5vFavlnp6Z2Edl-vvEqctuoWWRxsce0130_assertion description "[TP53 mutations and cyclin-dependent kinase inhibitor 2A promoter methylation, but not alterations in the H-Ras and K-Ras genes, might be involved in the malignant progression of pleomorphic adenomas into carcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132284.RA6jbEI-skD8kY5vFavlnp6Z2Edl-vvEqctuoWWRxsce0130_provenance.
- NP215343.RAwJ1X2ywmpATg-EspuCFzpN3k0Zsjh_UTjC5W8sDKqoI130_assertion description "[TP53 mutations and cyclin-dependent kinase inhibitor 2A promoter methylation, but not alterations in the H-Ras and K-Ras genes, might be involved in the malignant progression of pleomorphic adenomas into carcinoma ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215343.RAwJ1X2ywmpATg-EspuCFzpN3k0Zsjh_UTjC5W8sDKqoI130_provenance.